The aim of this study was to investigate the expression of HIP1R and confirm its predictive or prognostic roles in anti-PD-1 therapy in nonsmall cell lung cancer (NSCLC) patients. This evidence concerns the gene HIP1R and non-small cell lung carcinoma.